On May 13, 2025, OmniAb, Inc. showcased its xPloration high-throughput single B-cell screening platform at the 21st Annual PEGS Boston Summit. The presentation, titled 'xPloration: Simplifying Deep Antibody Mining for Maximum Impact,' detailed the platform's capabilities.
xPloration processes millions of single B-cells and recovers thousands of antibody variants within hours, offering a 10 times higher single cell screening throughput compared to other spatial separation techniques. Its laser-based recovery process enables touchless sorting of live cells, with rapid instrument run times of approximately 1.5 hours.
The platform features a fluidics-free system for improved reliability and AI-assisted image analysis for ease-of-use, minimizing maintenance and training requirements. The presentation also demonstrated xPloration's versatility across various assay formats, including multiplex cell surface binding and cross-blocking assays, which can unlock specific antibody profiles for partners.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.